Skip to main content
. Author manuscript; available in PMC: 2019 Feb 6.
Published in final edited form as: Clin Infect Dis. 2008 Nov 15;47(10):1328–1338. doi: 10.1086/592691

Figure 3.

Figure 3.

Pneumococcal vaccine effectiveness against invasive pneumococcal disease by age of recipient and time since vaccination. The point estimate of vaccine effectiveness and 95% CI are indicated. Within each age group, 3 data points represent the vaccine effectiveness at <3 years, 3–5 years, and >5 years since vaccination, from left to right. Data adapted from Shapiro et al. [5].